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Acute myopia following use of some drugs is a relatively rare condition. Topiramate prescribed for seizure 
prophylaxis is one of these drugs.  In this paper a case of acute transient myopia after taking topiramate is 
reported.
The reported patient is a 28-year old woman who had no history of any eye disease. Following consumption 
of topiramate pill for one week, she had found blurred vision since one day prior to the admission. A 
complete ocular examinations revealed acute bilateral myopia. This disease was resolved about 48 hours 
after discontinuation of topiromate. Due to the wide spectrum of indications for the administration of 
Topiramate, neurologists and psychiatrists should be aware of its ocular side effects. In conclusion, ocular 
complications following this drug should be taken seriously and be subjected to ophthalmic counsaltation.
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Journal of Kerman University of Medical Sciences, 2013; 20(1): 96-101 
 
 
 
